13don MSN
AstraZeneca Pharma India shares surge over 3% on new Hyperkalaemia drug deal with Sun Pharma
AstraZeneca Pharma India shares may be in focus after the company announced a second brand partnership with Sun Pharma to ...
In the phase 2 MIRO-CKD trial, investigators tested a novel MRA in combination with an SGLT2 inhibitor and included patients with higher serum potassium levels than 4.8 mmol/L at baseline and patients ...
Unhealthy diets are a major impediment to achieving a healthier population in the United States. Although there is a relatively clear sense of what constitutes a healthy diet, most of the US ...
New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has recommended approval for AstraZeneca India Pharma Limited's proposal to ...
View all available purchase options and get full access to this article.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results